SCHEMBL7511754

SCHEMBL7511754

CCOC(=O)c1nn(CCC(F)(F)F)cc1[N+](=O)[O-]

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
LMNA P02545 2/20 0.44
PTGS1 P23219 1/20 0.44
PTGS2 P35354 1/20 0.44
ALDH1A1 P00352 5/20 0.44
MAPT P10636 2/20 0.43
ADORA3 P0DMS8 2/20 0.41
ADORA2A P29274 2/20 0.41
ADORA1 P30542 2/20 0.41
MITF O75030 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
GALR2 O43603 1/20 0.39
HSP90AA1 P07900 1/20 0.39
HPGD P15428 1/20 0.39
XBP1 P17861 1/20 0.39
CCR6 P51684 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28805098 0.89 ALDH1A1 (0.43) POLBMEN1KMT2ALMNAALDH1A1
SCHEMBL7513311 0.88 POLB (0.46) POLBMEN1KMT2ALMNAPTGS1
SCHEMBL7515726 0.83 ALDH1A1 (0.60) POLBMEN1KMT2ALMNAPTGS1
SCHEMBL7517984 0.83 MEN1 (0.48) POLBMEN1KMT2ALMNAPTGS1
SCHEMBL8302429 0.81 LMNA (0.61) POLBMEN1KMT2ALMNAPTGS1
SCHEMBL7515929 0.81 L3MBTL1 (0.47) MEN1KMT2ALMNAALDH1A1MITF
SCHEMBL1876257 0.79 ADORA3 (0.60) MEN1KMT2ALMNAPTGS1PTGS2
SCHEMBL7511662 0.77 ALDH1A1 (0.47) POLBMEN1KMT2ALMNAPTGS1
SCHEMBL17459107 0.77 LMNA (0.52) MEN1KMT2ALMNAPTGS1PTGS2
SCHEMBL27912638 0.76 ALDH1A1 (0.45) POLBMEN1KMT2ALMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2580207-B1 NITROGEN CONTAINING HETEROARYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2017-09-27 EP disclosed
US-8703768-B2 Nitrogen containing heteroaryl compounds HOFFMANN-LA ROCHE INC. (US) 2014-04-22 US disclosed
US-8623866-B2 2014-01-07 US disclosed
EP-2580207-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2013-04-17 EP disclosed
WO-2011154327-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 WO disclosed
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS PDE10A, PDE3A, PDE2A POLB 1698/4885MEN1 985/4885KMT2A 2177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.